Dashboard
Financial statements
IQV

Company financials

IQVIA

Health Care Life Sciences Tools & Services Durham, North Carolina Last filing Feb 17, 2026 · FY2025
Revenue FY2025
$16.3B
3y CAGR +4.2% P47
Net income FY2025
$1.4B
Net margin +8.3% P29
Total assets FY2025
$29.9B
ROA +4.5% P41
Operating cash flow FY2025
$2.7B
FCF margin +12.6% P37
15 yrs · FY2011–FY2025 9 filed · 0 derived · 0 blank

Running CAGR since the earliest displayed year.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 10 years
Total assets $29.9B
Total liabilities $23.3B
Shareholders equity $6.5B
Account 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Trend
Assets
Cash and Cash Equivalents +5.7% +4.5% +2.0% +0.2% +2.7% +10.9% -11.3% -13.8% -19.9% —
Short Term Investments +16.7% +17.1% +17.0% +15.1% +22.6% +21.8% +15.7% +8.4% +15.0% —
Accounts Receivable +8.0% +8.2% +10.3% +9.3% +8.4% +9.0% +14.8% +18.4% +16.8% —
Prepaid Expenses +3.1% +2.8% +2.0% +3.5% +4.9% +6.6% +3.9% +10.8% +18.7% —
Other Current Assets +8.2% +11.2% +11.5% +14.4% +16.6% +23.2% +23.5% +20.6% +13.8% —
Total Current Assets +7.2% +7.2% +7.7% +6.9% +7.4% +11.1% +7.3% +7.7% +3.4% —
Property,Plant and Equipment +3.1% +3.5% +3.7% +4.6% +4.1% +4.4% +4.1% +3.4% +8.4% —
Operating Lease Assets — — — — — — — — — —
Goodwill +5.0% +4.0% +4.5% +4.4% +4.4% +4.2% +4.3% +4.9% +10.5% —
Intangible Assets -2.8% -4.3% -3.9% -4.6% -5.0% -5.0% -4.8% -3.5% +3.1% —
Long Term Investments +42.9% +45.8% +39.6% +39.1% +46.6% +59.4% +88.4% +178.7% -38.5% —
Deferred Tax Assets +16.7% +10.2% +9.3% +4.8% +6.9% +6.4% +10.2% +10.7% +10.1% —
Other Noncurrent Assets +10.7% +12.4% +12.5% +14.0% +18.2% +17.2% +5.9% +6.7% +24.0% —
Total Assets +3.9% +3.0% +3.3% +3.0% +3.1% +3.7% +3.1% +3.1% +7.2% —
Liabilities
Accrued Liabilities -23.5% -25.1% -31.1% -31.6% -38.6% -49.5% -59.0% -74.8% +10.6% —
Deferred Revenue +11.8% +11.0% +12.8% +15.1% +18.7% +12.8% +9.4% +14.1% -5.3% —
Current Portion of Long Term Debt — — — — — — — — — —
Other Current Liabilities +81.3% +93.2% +112.1% +136.1% +175.7% +251.6% +414.4% +978.7% -50.0% —
Total Current Liabilities +13.3% +12.5% +13.3% +12.8% +14.1% +13.9% +13.4% +14.3% +7.4% —
Long Term Debt +7.7% +7.7% +9.0% +10.0% +11.1% +14.9% +17.5% +23.9% +42.4% —
Operating Lease Liabilities Noncurrent — — — — — — — — — —
Deferred Tax Liabilities -24.1% -25.8% -28.6% -22.4% -28.1% -36.9% -32.8% -41.3% -57.0% —
Other Noncurrent Liabilities +6.2% +6.6% +8.2% +8.9% +10.1% +12.0% +4.3% +2.0% +9.5% —
Total Liabilities +7.3% +6.8% +7.6% +8.0% +8.6% +10.3% +11.2% +12.4% +16.5% —
Equity
Common Stock +0.8% +0.6% +0.6% +0.5% +0.3% +1.1% +1.4% +1.4% +1.7% —
Retained Earnings — — — — — — — — — —
Treasury Stock +31.0% +33.5% +36.3% +40.6% +45.7% +57.6% +79.0% +118.4% +237.4% —
Accumulated Other Comprehensive Income — — — — — — — — — —
Total Stockholders Equity -3.1% -4.3% -4.8% -6.5% -6.9% -8.7% -11.4% -11.8% -6.1% —
Noncontrolling Interest -6.2% — — — — +5.3% +4.6% +2.8% +9.7% —
Total Liabilitiesand Equity +3.9% +3.0% +3.3% +3.0% +3.1% +3.7% +3.1% +3.1% +7.2% —

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years
Ratio 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Profitability
Gross margin +33.3% +34.9% +35.0% +34.9% +33.5% +34.0% +34.2% +35.2% — —
Operating margin +13.4% +14.3% +13.2% +12.5% +10.0% +6.4% +7.0% +7.1% +7.4% +9.3%
Net margin +8.3% +8.9% +9.1% +7.6% +7.0% +2.5% +1.7% +2.5% +13.4% +1.7%
FCF margin +12.6% +13.7% +10.0% +11.0% +16.6% +11.8% +7.5% +7.6% +6.2% +10.1%
Growth
Revenue CAGR (3y) +4.2% +3.6% +9.7% +9.1% +10.0% +5.3% +17.3% +22.0% +21.3% +10.5%
Returns
ROE +20.9% +22.6% +22.2% +18.9% +16.0% +4.6% +3.2% +3.9% +16.1% +1.3%
ROA +4.5% +5.1% +5.1% +4.3% +3.9% +1.1% +0.8% +1.1% +5.8% +0.5%
ROIC +9.1% +9.8% +10.0% +8.4% +7.1% +3.5% +3.1% +3.6% +4.2% +1.2%
Liquidity
Current ratio 0.75x 0.84x 0.86x 0.89x 0.91x 1.12x 1.05x 1.10x 1.19x 1.23x
Quick ratio 0.65x 0.71x 0.73x 0.74x 0.75x 0.93x 0.87x 0.93x 1.02x 1.07x
Leverage
D/E 3.59x 3.43x 3.37x 3.39x 3.09x 3.05x 2.83x 2.32x 1.77x 1.43x
Interest coverage 2.99x 3.29x 2.94x 4.32x 3.71x 1.76x 1.74x 1.79x 2.08x 4.46x
Efficiency
Asset turnover 0.54x 0.57x 0.56x 0.57x 0.56x 0.46x 0.48x 0.46x 0.43x 0.32x
Cash conversion cycle — — — — — — — — — —

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds IQV to your watchlist.